Intervention not reported
Bupropion therapy plus behavioral support versus self‐help (continuous waterpipe smoking abstinence, defined as an expired CO of 9 ppm or less at the 6‐month postintervention · people who use waterpipe
It is very uncertain whether the intervention changes bupropion therapy plus behavioral support versus self‐help… (very low certainty).
1 finding from 1 review
RR 1.94 [0.94, 4]
86 participants
Very low
Intervention not reported
E‐health interventions · people who use waterpipe
It is very uncertain whether the intervention changes E‐health interventions (very low certainty).
1 finding from 1 review
Cognitive function · people with dementia
1 finding from 1 review
Communication and social interaction · people with dementia
1 finding from 1 review
Mood · people with dementia
1 finding from 1 review
Mood: interviewer/staff‐rated · people with dementia
1 finding from 1 review
Instrumental ADL · people with dementia
1 finding from 1 review
Behaviour that challenges · people with dementia
1 finding from 1 review
Quality of Life: self‐report · people with dementia
1 finding from 1 review
Communication and social interaction · people with dementia
1 finding from 1 review
Mood · people with dementia
1 finding from 1 review
Mood: interviewer/staff‐rated · people with dementia
1 finding from 1 review
Instrumental ADL · people with dementia
1 finding from 1 review
Behaviour that challenges · people with dementia
1 finding from 1 review
Cognitive function · people with dementia
1 finding from 1 review
Quality of Life: self‐report · people with dementia
1 finding from 1 review
Intervention not reported
Presence of PHN 6 months after the onset of acute herpetic rashClinical manifestation · people with acute herpes zoster (within 7 days of onset of rash)
It is very uncertain whether the intervention changes presence of PHN 6 months after the onset of acute herpetic… (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse eventsClinical manifestation and laboratory examination · people with acute herpes zoster (within 7 days of onset of rash)
It is very uncertain whether the intervention changes serious adverse eventsClinical manifestation and laboratory… (very low certainty).
1 finding from 1 review
Intervention not reported
Non‐serious adverse eventsClinical manifestation and laboratory examination · people with acute herpes zoster (within 7 days of onset of rash)
The intervention showed no clear difference in non‐serious adverse eventsClinical manifestation and laboratory… (low certainty).
1 finding from 1 review
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in death or dependence (mRS 4–6) compared with placebo/open control (low certainty).
1 finding from 1 review